122 related articles for article (PubMed ID: 1279607)
1. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle.
Huikuri HV; Yli-Mäyry S
Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2103-7. PubMed ID: 1279607
[TBL] [Abstract][Full Text] [Related]
2. Frequency-dependent electrophysiologic effects of amiodarone in humans.
Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
[TBL] [Abstract][Full Text] [Related]
3. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
Martínez-Rubio A; Shenasa M; Chen X; Wichter T; Breithardt G; Borggrefe M
Am J Cardiol; 1994 Feb; 73(5):357-60. PubMed ID: 7509121
[TBL] [Abstract][Full Text] [Related]
4. Rate and time dependent effects of D-sotalol on the monophasic action potential after sudden increase of the heart rate.
Melichercik J; Brachmann J; Schöls W; Hilbel T; Beyer T; Kübler W
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 1):65-72. PubMed ID: 9990602
[TBL] [Abstract][Full Text] [Related]
5. Use-dependent electrophysiologic effects of DL-sotalol and modulation by isoproterenol in the human ventricle.
Naitoh N; Furushima H; Ohira K; Taneda K; Aizawa Y
Jpn Heart J; 1998 Mar; 39(2):153-61. PubMed ID: 9687824
[TBL] [Abstract][Full Text] [Related]
6. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle.
Schmitt C; Brachmann J; Karch M; Waldecker B; Navarrete L; Montero M; Beyer T; Kübler W
Am J Cardiol; 1991 Nov; 68(11):1183-7. PubMed ID: 1951078
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
8. Class III antiarrhythmic action of d-sotalol during hypothermia.
Bjørnstad H; Tande PM; Refsum H
Am Heart J; 1991 May; 121(5):1429-36. PubMed ID: 2017975
[TBL] [Abstract][Full Text] [Related]
9. Reverse use dependence of human ventricular repolarization by chronic oral sotalol in monophasic action potential recordings.
Shimizu W; Kurita T; Suyama K; Aihara N; Kamakura S; Shimomura K
Am J Cardiol; 1996 May; 77(11):1004-8. PubMed ID: 8644624
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.
Vanoli E; Priori SG; Nakagawa H; Hirao K; Napolitano C; Diehl L; Lazzara R; Schwartz PJ
J Am Coll Cardiol; 1995 Jun; 25(7):1609-14. PubMed ID: 7759713
[TBL] [Abstract][Full Text] [Related]
11. Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans.
Nademanee K; Stevenson WG; Weiss JN; Frame VB; Antimisiaris MG; Suithichaiyakul T; Pruitt CM
Circulation; 1990 Mar; 81(3):790-6. PubMed ID: 2306831
[TBL] [Abstract][Full Text] [Related]
12. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
13. A comparison of electrophysiologic properties between responders and non-responders to DL-sotalol among patients with ventricular tachyarrhythmia. Importance of the lack of a reverse use-dependent effect on ventricular refractoriness to responders.
Naitoh N; Yamaura M; Tagawa M; Aizawa Y
Jpn Heart J; 1998 Sep; 39(5):619-30. PubMed ID: 9925993
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
Merot J; Charpentier F; Poirier JM; Coutris G; Weissenburger J
Cardiovasc Res; 1999 Nov; 44(2):303-14. PubMed ID: 10690307
[TBL] [Abstract][Full Text] [Related]
15. Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart.
Eckardt L; Haverkamp W; Göttker U; Madeja M; Johna R; Borggrefe M; Breithardt G
J Cardiovasc Electrophysiol; 1998 Apr; 9(4):366-83. PubMed ID: 9581953
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
Lee SD; Newman D; Ham M; Dorian P
J Am Coll Cardiol; 1997 Jan; 29(1):100-5. PubMed ID: 8996301
[TBL] [Abstract][Full Text] [Related]
17. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias.
Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME
Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498
[TBL] [Abstract][Full Text] [Related]
18. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
Aliot E; Sadoul N; De Chillou C
Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940
[TBL] [Abstract][Full Text] [Related]
19. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
Sager PT; Behboodikhah M
J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M
J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]